Article Information
PubMed
Print ISSN
Online ISSN
History
- Published online June 21, 2006.
Article Versions
- Earlier version (April 12, 2006 - 11:31).
- You are viewing the most recent version of this article.
Copyright & Usage
The American Society for Pharmacology and Experimental Therapeutics
Author Information
- Naoki Ishiguro,
- Kazuya Maeda,
- Wataru Kishimoto,
- Asami Saito,
- Akiko Harada,
- Thomas Ebner,
- Willy Roth,
- Takashi Igarashi and
- Yuichi Sugiyama
- Department of Pharmacokinetics and Non-Clinical Safety, Kawanishi Pharma Research Institute, Nippon Boehringer Ingelheim Co., Ltd., Hyogo, Japan (N.I., W.K., A.S., A.H., T.I.); Department of Molecular Pharmacokinetics, Graduate School of Pharmaceutical Sciences, the University of Tokyo, Tokyo, Japan (K.M., Y.S.); and Department of Pharmacokinetics and Drug Metabolism, Boehringer Ingelheim Pharma KG, Biberach on der Riss, Germany (T.E., W.R.)
- Address correspondence to:
Dr. Yuichi Sugiyama, Department of Molecular Pharmacokinetics, Graduate School of Pharmaceutical Sciences, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-0033, Japan. E-mail: sugiyama{at}mol.f.u-tokyo.ac.jp
Statistics from Altmetric.com
Article usage
In this issue
PREDOMINANT CONTRIBUTION OF OATP1B3 TO THE HEPATIC UPTAKE OF TELMISARTAN, AN ANGIOTENSIN II RECEPTOR ANTAGONIST, IN HUMANS
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement